Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 Mar;69(3):580–585. doi: 10.1038/bjc.1994.106

Soluble E-cadherin fragments increased in circulation of cancer patients.

M Katayama 1, S Hirai 1, K Kamihagi 1, K Nakagawa 1, M Yasumoto 1, I Kato 1
PMCID: PMC1968869  PMID: 8123491

Abstract

Monoclonal antibodies were raised against human placental soluble E-cadherins and used in an immunoenzymometric assay to detect soluble E-cadherins in biological fluids. The E-cadherin assay was accurate enough to quantitate the concentration of soluble E-cadherin in the cell culture supernatants. Immunoreactive E-cadherins, identified as existing in the soluble form in normal serum, were shown to have apparent lower molecular mass (approximately 80 kDa) than intact molecules of E-cadherin. We found that the immunoreactive E-cadherin levels in the serum of the studied cancer patients were significantly elevated (mean +/- s.d. 3.80 +/- 2.36 micrograms ml-1, P < 0.0001) when compared with the normal levels (1.99 +/- 0.50 micrograms ml-1). We also found that serum E-cadherin levels in the 22 patients with gastric cancer (3.51 +/- 1.78 micrograms ml-1, P < 0.02) or the 11 patients with hepatocellular cancer (5.55 +/- 3.11 micrograms ml-1, P < 0.001) were significantly higher than those in the 26 diabetic patients (2.33 +/- 1.58 micrograms ml-1). Of the 54 cancer patients, 53.7% exhibited an elevated amount of soluble E-cadherin in serum. Thus, it is evident that soluble E-cadherin in circulation can be used as a prospective tumour marker that accurately reflects the progressive regeneration of E-cadherin at tumour sites, potentially induced by tumour-associated proteolytic degradation.

Full text

PDF
580

Images in this article

582Figure 1
on p.582
583Figure 4
on p.583

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Behrens J., Mareel M. M., Van Roy F. M., Birchmeier W. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol. 1989 Jun;108(6):2435–2447. doi: 10.1083/jcb.108.6.2435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brocks D. G., Strecker H., Neubauer H. P., Timpl R. Radioimmunoassay of laminin in serum and its application to cancer patients. Clin Chem. 1986 May;32(5):787–791. [PubMed] [Google Scholar]
  3. Bussemakers M. J., van Moorselaar R. J., Giroldi L. A., Ichikawa T., Isaacs J. T., Takeichi M., Debruyne F. M., Schalken J. A. Decreased expression of E-cadherin in the progression of rat prostatic cancer. Cancer Res. 1992 May 15;52(10):2916–2922. [PubMed] [Google Scholar]
  4. Chen W. C., Obrink B. Cell-cell contacts mediated by E-cadherin (uvomorulin) restrict invasive behavior of L-cells. J Cell Biol. 1991 Jul;114(2):319–327. doi: 10.1083/jcb.114.2.319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Damsky C. H., Richa J., Solter D., Knudsen K., Buck C. A. Identification and purification of a cell surface glycoprotein mediating intercellular adhesion in embryonic and adult tissue. Cell. 1983 Sep;34(2):455–466. doi: 10.1016/0092-8674(83)90379-3. [DOI] [PubMed] [Google Scholar]
  6. Feldman L. E., Shin K. C., Natale R. B., Todd R. F., 3rd Beta 1 integrin expression on human small cell lung cancer cells. Cancer Res. 1991 Feb 15;51(4):1065–1070. [PubMed] [Google Scholar]
  7. Frixen U. H., Behrens J., Sachs M., Eberle G., Voss B., Warda A., Löchner D., Birchmeier W. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol. 1991 Apr;113(1):173–185. doi: 10.1083/jcb.113.1.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Giard D. J., Aaronson S. A., Todaro G. J., Arnstein P., Kersey J. H., Dosik H., Parks W. P. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst. 1973 Nov;51(5):1417–1423. doi: 10.1093/jnci/51.5.1417. [DOI] [PubMed] [Google Scholar]
  9. Goldfarb R. H., Liotta L. A. Proteolytic enzymes in cancer invasion and metastasis. Semin Thromb Hemost. 1986 Oct;12(4):294–307. doi: 10.1055/s-2007-1003570. [DOI] [PubMed] [Google Scholar]
  10. Hamaguchi M., Matsuyoshi N., Ohnishi Y., Gotoh B., Takeichi M., Nagai Y. p60v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion system. EMBO J. 1993 Jan;12(1):307–314. doi: 10.1002/j.1460-2075.1993.tb05658.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hashimoto M., Niwa O., Nitta Y., Takeichi M., Yokoro K. Unstable expression of E-cadherin adhesion molecules in metastatic ovarian tumor cells. Jpn J Cancer Res. 1989 May;80(5):459–463. doi: 10.1111/j.1349-7006.1989.tb02336.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hixson D. C., McEntire K. D., Obrink B. Alterations in the expression of a hepatocyte cell adhesion molecule by transplantable rat hepatocellular carcinomas. Cancer Res. 1985 Aug;45(8):3742–3749. [PubMed] [Google Scholar]
  13. Katayama M., Kamihagi K., Hirai S., Kurome T., Murakami K., Hino F., Kato I. Urinary laminin fragments as a tumour marker potentially reflecting basement membrane destruction. Br J Cancer. 1992 Apr;65(4):509–514. doi: 10.1038/bjc.1992.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Katayama M., Kurome T., Yamamoto K., Uchida H., Hino F., Kato I. Sandwich enzyme immunoassay for serum integrins using monoclonal antibodies. Clin Chim Acta. 1991 Oct 31;202(3):179–190. doi: 10.1016/0009-8981(91)90048-h. [DOI] [PubMed] [Google Scholar]
  15. Larjava H., Peltonen J., Akiyama S. K., Yamada S. S., Gralnick H. R., Uitto J., Yamada K. M. Novel function for beta 1 integrins in keratinocyte cell-cell interactions. J Cell Biol. 1990 Mar;110(3):803–815. doi: 10.1083/jcb.110.3.803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lotan R., Raz A. Low colony formation in vivo and in culture as exhibited by metastatic melanoma cells selected for reduced homotypic aggregation. Cancer Res. 1983 May;43(5):2088–2093. [PubMed] [Google Scholar]
  17. Mareel M. M., Behrens J., Birchmeier W., De Bruyne G. K., Vleminckx K., Hoogewijs A., Fiers W. C., Van Roy F. M. Down-regulation of E-cadherin expression in Madin Darby canine kidney (MDCK) cells inside tumors of nude mice. Int J Cancer. 1991 Apr 1;47(6):922–928. doi: 10.1002/ijc.2910470623. [DOI] [PubMed] [Google Scholar]
  18. Martìn-Padura I., Mortarini R., Lauri D., Bernasconi S., Sanchez-Madrid F., Parmiani G., Mantovani A., Anichini A., Dejana E. Heterogeneity in human melanoma cell adhesion to cytokine activated endothelial cells correlates with VLA-4 expression. Cancer Res. 1991 Apr 15;51(8):2239–2241. [PubMed] [Google Scholar]
  19. Matsuura K., Kawanishi J., Fujii S., Imamura M., Hirano S., Takeichi M., Niitsu Y. Altered expression of E-cadherin in gastric cancer tissues and carcinomatous fluid. Br J Cancer. 1992 Dec;66(6):1122–1130. doi: 10.1038/bjc.1992.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nagafuchi A., Takeichi M., Tsukita S. The 102 kd cadherin-associated protein: similarity to vinculin and posttranscriptional regulation of expression. Cell. 1991 May 31;65(5):849–857. doi: 10.1016/0092-8674(91)90392-c. [DOI] [PubMed] [Google Scholar]
  21. Navarro P., Gómez M., Pizarro A., Gamallo C., Quintanilla M., Cano A. A role for the E-cadherin cell-cell adhesion molecule during tumor progression of mouse epidermal carcinogenesis. J Cell Biol. 1991 Oct;115(2):517–533. doi: 10.1083/jcb.115.2.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ogou S. I., Yoshida-Noro C., Takeichi M. Calcium-dependent cell-cell adhesion molecules common to hepatocytes and teratocarcinoma stem cells. J Cell Biol. 1983 Sep;97(3):944–948. doi: 10.1083/jcb.97.3.944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pignatelli M., Liu D., Nasim M. M., Stamp G. W., Hirano S., Takeichi M. Morphoregulatory activities of E-cadherin and beta-1 integrins in colorectal tumour cells. Br J Cancer. 1992 Oct;66(4):629–634. doi: 10.1038/bjc.1992.328. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rasbridge S. A., Gillett C. E., Sampson S. A., Walsh F. S., Millis R. R. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol. 1993 Feb;169(2):245–250. doi: 10.1002/path.1711690211. [DOI] [PubMed] [Google Scholar]
  25. Reeves M. E. A metastatic tumor cell line has greatly reduced levels of a specific homotypic cell adhesion molecule activity. Cancer Res. 1992 Mar 15;52(6):1546–1552. [PubMed] [Google Scholar]
  26. Rothlein R., Mainolfi E. A., Czajkowski M., Marlin S. D. A form of circulating ICAM-1 in human serum. J Immunol. 1991 Dec 1;147(11):3788–3793. [PubMed] [Google Scholar]
  27. Schipper J. H., Frixen U. H., Behrens J., Unger A., Jahnke K., Birchmeier W. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res. 1991 Dec 1;51(23 Pt 1):6328–6337. [PubMed] [Google Scholar]
  28. Shimoyama Y., Hirohashi S. Cadherin intercellular adhesion molecule in hepatocellular carcinomas: loss of E-cadherin expression in an undifferentiated carcinoma. Cancer Lett. 1991 May 1;57(2):131–135. doi: 10.1016/0304-3835(91)90206-w. [DOI] [PubMed] [Google Scholar]
  29. Shimoyama Y., Hirohashi S. Expression of E- and P-cadherin in gastric carcinomas. Cancer Res. 1991 Apr 15;51(8):2185–2192. [PubMed] [Google Scholar]
  30. Shimoyama Y., Hirohashi S., Hirano S., Noguchi M., Shimosato Y., Takeichi M., Abe O. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res. 1989 Apr 15;49(8):2128–2133. [PubMed] [Google Scholar]
  31. Shimoyama Y., Nagafuchi A., Fujita S., Gotoh M., Takeichi M., Tsukita S., Hirohashi S. Cadherin dysfunction in a human cancer cell line: possible involvement of loss of alpha-catenin expression in reduced cell-cell adhesiveness. Cancer Res. 1992 Oct 15;52(20):5770–5774. [PubMed] [Google Scholar]
  32. Suzuki S., Sano K., Tanihara H. Diversity of the cadherin family: evidence for eight new cadherins in nervous tissue. Cell Regul. 1991 Apr;2(4):261–270. doi: 10.1091/mbc.2.4.261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Symons J. A., Wood N. C., Di Giovine F. S., Duff G. W. Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition. J Immunol. 1988 Oct 15;141(8):2612–2618. [PubMed] [Google Scholar]
  34. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 1991 Mar 22;251(5000):1451–1455. doi: 10.1126/science.2006419. [DOI] [PubMed] [Google Scholar]
  35. Takeichi M. The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development. 1988 Apr;102(4):639–655. doi: 10.1242/dev.102.4.639. [DOI] [PubMed] [Google Scholar]
  36. Umbas R., Schalken J. A., Aalders T. W., Carter B. S., Karthaus H. F., Schaafsma H. E., Debruyne F. M., Isaacs W. B. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res. 1992 Sep 15;52(18):5104–5109. [PubMed] [Google Scholar]
  37. Vestweber D., Kemler R. Rabbit antiserum against a purified surface glycoprotein decompacts mouse preimplantation embryos and reacts with specific adult tissues. Exp Cell Res. 1984 May;152(1):169–178. doi: 10.1016/0014-4827(84)90241-6. [DOI] [PubMed] [Google Scholar]
  38. Vleminckx K., Vakaet L., Jr, Mareel M., Fiers W., van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell. 1991 Jul 12;66(1):107–119. doi: 10.1016/0092-8674(91)90143-m. [DOI] [PubMed] [Google Scholar]
  39. Wheelock M. J., Buck C. A., Bechtol K. B., Damsky C. H. Soluble 80-kd fragment of cell-CAM 120/80 disrupts cell-cell adhesion. J Cell Biochem. 1987 Jul;34(3):187–202. doi: 10.1002/jcb.240340305. [DOI] [PubMed] [Google Scholar]
  40. Yoshida-Noro C., Suzuki N., Takeichi M. Molecular nature of the calcium-dependent cell-cell adhesion system in mouse teratocarcinoma and embryonic cells studied with a monoclonal antibody. Dev Biol. 1984 Jan;101(1):19–27. doi: 10.1016/0012-1606(84)90112-x. [DOI] [PubMed] [Google Scholar]
  41. Yoshida C., Takeichi M. Teratocarcinoma cell adhesion: identification of a cell-surface protein involved in calcium-dependent cell aggregation. Cell. 1982 Feb;28(2):217–224. doi: 10.1016/0092-8674(82)90339-7. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES